{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:22:28Z","timestamp":1786990948687,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","award":["C06 CA059267"],"award-info":[{"award-number":["C06 CA059267"]}],"id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ijrobp.2025.03.010","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T20:57:00Z","timestamp":1741899420000},"page":"1301-1309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Long-Term Results of a Phase 2 Study of Adjuvant Proton Radiation Therapy for Node-Positive Cancer of the Uterus and Cervix"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7900-6127","authenticated-orcid":false,"given":"Andrea L.","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Depauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora K.","family":"Horick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Y.","family":"Wo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A.","family":"Nyamwanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fantine","family":"Giap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilana","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela G.","family":"Del Carmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annekathryn","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Penson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"DeLaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony H.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.03.010_bib0001","unstructured":"American Cancer Society. Key statistics for endometrial cancer. Available at: https:\/\/www.cancer.org\/cancer\/endometrial-cancer\/about\/key-statistics.html. Accessed October 3, 2022."},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0002","unstructured":"Surveillance, Epidemiology, and End Results (SEER). Cancer Stat Facts: Uterine cancer. Available at: https:\/\/seer.cancer.gov\/statfacts\/html\/corp.html. Accessed October 3, 2022."},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0003","unstructured":"Surveillance, Epidemiology, and End Results (SEER). Cancer Stat Facts: cervical cancer. Available at: https:\/\/seer.cancer.gov\/statfacts\/html\/cervix.html. Accessed October 3, 2022."},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0004","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ygyno.2007.12.002","article-title":"Survival for stage IB cervical cancer with positive lymph node involvement: A comparison of completed vs. abandoned radical hysterectomy","volume":"109","author":"Richard","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0005","unstructured":"National Comprehensive Cancer Network. NCCN Guidelines. Version 3.2021 Uterine neoplasms. 2021. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/uterine.pdf. Accessed August 22, 2021."},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0006","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa1813181","article-title":"Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer","volume":"380","author":"Matei","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0007","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0008","unstructured":"NCCN, Cervical Cancer, National Comprehensive Cancer Network Guidelines, 1, 2021, 1\u201390. Available at: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1426. Accessed January 2, 2025."},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0009","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1200\/JCO.21.02831","article-title":"Intensity-modulated radiation therapy reduces patient-reported chronic toxicity compared with conventional pelvic radiation therapy: Updated results of a phase III trial","volume":"40","author":"Yeung","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0010","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1200\/JCO.20.02530","article-title":"Late toxicity after adjuvant conventional radiation versus image-guided intensity-modulated radiotherapy for cervical cancer (PARCER): A randomized controlled trial","volume":"39","author":"Chopra","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0011","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.4103\/jcrt.jcrt_597_21","article-title":"Clinical impact of extended field radiation therapy in Stage III carcinoma cervix versus conventional field techniques: A comparative study","volume":"18","author":"Daga","year":"2022","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0012","doi-asserted-by":"crossref","first-page":"e409","DOI":"10.1016\/j.prro.2023.03.010","article-title":"Prophylactic extended-field irradiation versus pelvic irradiation in patients with cervical cancer with 2018 FIGO stage IIIC1 disease","volume":"13","author":"Wang","year":"2023","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0013","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.canrad.2016.06.007","article-title":"Toxicity and early clinical outcomes in cervical cancer following extended field helical tomotherapy to para-aortic lymph nodes","volume":"20","author":"Jouglar","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0014","series-title":"Proton and Charged Particle Radiotherapy","year":"2008"},{"issue":"suppl 1","key":"10.1016\/j.ijrobp.2025.03.010_bib0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ijgo.13866","article-title":"Cancer of the corpus uteri: 2021 update","volume":"155","author":"Koskas","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0016","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijgo.12749","article-title":"Revised FIGO staging for carcinoma of the cervix uteri","volume":"145","author":"Bhatla","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0017","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1159\/000503095","article-title":"Performance status assessment by using ECOG (Eastern Cooperative Oncology Group) score for cancer patients by oncology healthcare professionals","volume":"12","author":"Azam","year":"2019","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0018","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ygyno.2006.02.007","article-title":"Final analysis of RTOG 9708: Adjuvant postoperative irradiation combined with cisplatin\/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer","volume":"103","author":"Greven","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0019","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijrobp.2004.03.035","article-title":"IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk","volume":"60","author":"Ahmed","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0360-3016(92)90676-9","article-title":"Radiation therapy for surgically proven para-aortic node metastasis in endometrial carcinoma","volume":"24","author":"Rose","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0021","article-title":"Extended-field radiotherapy for locally advanced cervical cancer","volume":"10","author":"Thamronganantasakul","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0022","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(94)00337-K","article-title":"Conventional four-field pelvic radiotherapy technique without computed tomography-treatment planning in cancer of the cervix: Potential geographic miss and its impact on pelvic control","volume":"31","author":"Kim","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0023","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ijrobp.2007.09.042","article-title":"Consensus guidelines for the delineation of the clinical target volume for intensity modulated pelvic radiotherapy in the postoperative treatment of endometrial and cervical cancer","volume":"71","author":"William Small","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0024","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijrobp.2015.12.368","article-title":"Impact of spot size and beam-shaping devices on the treatment plan quality for pencil beam scanning proton therapy","volume":"95","author":"Moteabbed","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0025","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20120288","article-title":"Treatment planning optimisation in proton therapy","volume":"86","author":"McGowan","year":"2013","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0026","unstructured":"National Institutes of Health. Common Terminology Criteria for Adverse Events (CTCAE). version 4.0. 2009, Available at: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm#ctc_40. Accessed April 8, 2025."},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0027","unstructured":"FACIT Group. FACT-En. Functional assessment of cancer therapy \u2013 endometrial. Available at: https:\/\/www.facit.org\/measures\/fact-en. Accessed November 15, 2024."},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0028","unstructured":"FACIT Group. FACT-Cx. Functional assessment of cancer therapy \u2013 cervix. Available at: https:\/\/www.facit.org\/measures\/fact-cx. Accessed November 15, 2024."},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0029","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/0163278705275340","article-title":"Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience","volume":"28","author":"Yost","year":"2005","journal-title":"Eval Health Prof"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0030","unstructured":"European Society for Medical Oncology. Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Available at:https:\/\/www.esmo.org\/guidelines\/guidelines-by-topic\/esmo-clinical-practice-guidelines-gynaecological-cancers\/clinical-practice-guideline-endometrial-cancer. Accessed November 16, 2024."},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0031","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ygyno.2023.03.003","article-title":"Acute and long-term toxicity of whole pelvis proton radiation therapy for definitive or adjuvant management of gynecologic cancers","volume":"172","author":"Berlin","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0032","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1016\/j.ijrobp.2011.07.012","article-title":"Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies","volume":"82","author":"Milby","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0033","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ijrobp.2023.01.004","article-title":"Treatment tolerability and toxicity of postoperative proton beam therapy for gynecologic malignancies: Results of the prospective phase 2 APROVE trial","volume":"116","author":"Arians","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0034","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13014-023-02198-4","article-title":"Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial","volume":"18","author":"Meixner","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14338\/IJPT-22-00020.1","article-title":"Outcomes of proton beam therapy compared with intensity-modulated radiation therapy for uterine cancer","volume":"9","author":"Anderson","year":"2023","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0036","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.3390\/cancers13205179","article-title":"PROTECT: Prospective phase-II-trial evaluating adaptive proton therapy for cervical cancer to reduce the impact on morbidity and the immune system","volume":"13","author":"Corbeau","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0037","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1200\/JCO.2017.77.4273","article-title":"Patient-reported toxicity during pelvic intensity-modulated radiation therapy: NRG Oncology-RTOG 1203","volume":"36","author":"Klopp","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0038","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1200\/JCO.19.02381","article-title":"Improvement in patient-reported outcomes with intensity-modulated radiotherapy (RT) compared with standard RT: A report from the NRG Oncology RTOG 1203 study","volume":"38","author":"Yeung","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0039","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijrobp.2007.03.018","article-title":"Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: A treatment planning comparison","volume":"69","author":"Trofimov","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0040","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20201289","article-title":"Volumetric modulated arc therapy (VMAT): A review of clinical outcomes-what is the clinical evidence for the most effective implementation?","volume":"95","author":"Hunte","year":"2022","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0041","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/cam4.924","article-title":"The relationship between ovarian function and ovarian limited dose in radiotherapy postoperation of ovarian transposition in young patients with cervical cancer","volume":"6","author":"Du","year":"2017","journal-title":"Cancer Med"},{"key":"10.1016\/j.ijrobp.2025.03.010_bib0042","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s12885-022-09695-x","volume":"22","author":"Hwang","year":"2022","journal-title":"BMC Cancer"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162500238X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162500238X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T22:50:52Z","timestamp":1762296652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030162500238X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S036030162500238X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.03.010","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Results of a Phase 2 Study of Adjuvant Proton Radiation Therapy for Node-Positive Cancer of the Uterus and Cervix","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}